PDF herunterladen
CC BY-NC-ND 4.0 · Endosc Int Open 2024; 12(08): E962-E967
DOI: 10.1055/a-2376-1913
Innovation forum

Direct endoscopic necrosectomy: Pilot study of a new dedicated device

Dario Ligresti 
1   Digestive Endoscopy Service, Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT, Palermo, Italy
,
Cecilia Binda 
2   Unit of Gastroenterology and Digestive Endoscopy, Morgagni-Pierantoni Hospital, Forli, Italy (Ringgold ID: RIN18568)
3   Unit of Gastroenterology and Digestive Endoscopy, Maurizio Bufalini Hospital, Cesena, Italy (Ringgold ID: RIN161128)
,
Alessandro Fugazza
4   Digestive Endoscopy Unit, Division of Gastroenterology, Humanitas Research Hospital, Rozzano, Italy
,
Marcello Maida 
5   Department of Medicine and Surgery, Università degli Studi di Enna 'Kore', Enna, Italy (Ringgold ID: RIN217140)
6   Gastroenterology Unit, Umberto I Hospital, Enna, Italy (Ringgold ID: RIN73129)
,
Mario Traina
1   Digestive Endoscopy Service, Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT, Palermo, Italy
,
Andrea Anderloni 
7   Gastroenterology and Digestive Endoscopy Unit, Viale Camillo Golgi, 19, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia (PV) 27100, Italy
,
Carlo Fabbri
8   Digestive Endoscopy and Gastroenterology Unit, Forlì-Cesena Hospitals, Azienda Unita Sanitaria Locale della Romagna, Forlì-Cesena, Italy (Ringgold ID: RIN390233)
,
Ilaria Tarantino
1   Digestive Endoscopy Service, Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT, Palermo, Italy
› InstitutsangabenGefördert durch: Italian Health Ministry ricerca corrente 2024
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Background and study aims Direct endoscopic necrosectomy (DEN) represents the first-line treatment for walled-off necrosis (WON). However, DEN has a non-negligible rate of overall adverse events (AE) and is time-consuming due to the lack of dedicated devices. This pilot study was designed to evaluate the feasibility and safety of a novel dedicated device for DEN named Necrolit.

Patients and methods In this multicenter retrospective analysis,16 patients with WON who underwent DEN using Necrolit were compared with a control group treated with non-dedicated devices. Technical success, AEs, clinical success, number of procedures per patient, procedure time, and length of hospital stay were evaluated. Necrolit technical performance indicators were also studied.

Results Technical success was obtained in all patients in both groups. In the Necrolit group, the overall AE rate was 10.1% vs. 15.9% in the control group. Clinical success was 100% in the Necrolit group vs. 81.3% in the control group. Patients treated with Necrolit underwent a slightly lower mean number of procedures (4.1 ± 2.3 vs. 5.1 ± 1.9) with comparable mean procedure time (67.8 ± 39 minutes vs. 70.1 ± 32.6 minutes). Mean duration of hospital stay was 39.4 days (± 30.9) in the Necrolit group vs. 43 days (± 29.4) in the control group. Device-related technical performance was rated positively.

Conclusions DEN with Necrolit appears feasible and safe.

Keywords

Endoscopic ultrasonography - Intervention EUS - Pancreas


Publikationsverlauf

Eingereicht: 31. Januar 2024

Angenommen nach Revision: 15. Mai 2024

Artikel online veröffentlicht:
23. August 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13: e1-15
    CrossrefPubMedSuche in Google Scholar
  • 2 Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-1261
    CrossrefPubMedSuche in Google Scholar
  • 3 Mohamadnejad M, Anushiravani A, Kasaeian A. et al. Endoscopic or surgical treatment for necrotizing pancreatitis: comprehensive systematic review and meta-analysis. Endosc Int Open 2022; 10: E420-E428
    Thieme ConnectPubMedSuche in Google Scholar
  • 4 van Brunschot S, van Grinsven J, van Santvoort HC. et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis: A multicentre randomised trial. Lancet 2018; 391: 51-58
    CrossrefPubMedSuche in Google Scholar
  • 5 Pinto S, Bellizzi S, Badas R. et al. Direct endoscopic necrosectomy: Timing and technique. Medicina 2021; 57: 1305
    CrossrefPubMedSuche in Google Scholar
  • 6 Fugazza A, Sethi A, Trindade AJ. et al. International multicenter comprehensive analysis of adverse events associated with lumen-apposing metal stent placement for pancreatic fluid collection drainage. Gastrointest. Endosc 2020; 91: 574-583
    PubMedSuche in Google Scholar
  • 7 van der Wiel SE, Poley JW, Grubben M. et al. The EndoRotor, a novel tool for the endoscopic management of pancreatic necrosis. Endoscopy 2018; 50: E240-E241
    Thieme ConnectPubMedSuche in Google Scholar
  • 8 Baron TH, Dimaio CJ, Wang AY. et al. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis. Gastroenterology 2020; 158: 67-75
    CrossrefPubMedSuche in Google Scholar
  • 9 European Commission. MEDDEV 2.7/1 revision 4. Clinical evaluation: a guide for manufacturers and notified bodies under directives 93/42/EEC and 90/385/EEC. http://ec.europa.eu/Docs Room/documents/17522/attachments/1/translations/
    PubMed
  • 10 Nass KJ, Zwager LW, van der Vlugt M. et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc 2022; 95: 1078-1085
    CrossrefPubMedSuche in Google Scholar